PAVmed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Debt (Details Narrative)

Debt (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended
Debt (Details Narrative) - USD ($)	Nov. 12, 2019	Dec. 27, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Change in fair value - Senior Secured Convertible Note			$ 379,229		$ (340,830)
Repayments of debt			$ 1,850,000		$ 3,381,000
Common stock, shares authorized			100,000,000		100,000,000		100,000,000
Interest expense				707,714		1,708,322
Senior Secured Convertible Note [Member]
Face value principal			$ 4,369,000		$ 4,369,000		$ 7,750,000
Conversion price			$ 1.60		$ 1.60		$ 1.60
Senior Secured Note [Member]
Interest expense				707,714		1,708,322
15% Interest Expense Senior Secured Note [Member]
Interest expense				201,867		$ 591,007
Interest expenses percentage						15.00%
Amortization of debt discount				$ 505,847		$ 1,117,315
Securities Purchase Agreement [Member] \| Senior Secured Convertible Note [Member]
Debt instrument maturity date		Dec. 31, 2020
Face value principal		$ 7,750,000
Interest rate		7.875%
Proceeds from senior convertible note		$ 7,000,000
Lender fees		750,000
Offering costs		614,940
Placement agent fee and legal fees		$ 455,000
Annual interest rate on bi-monthly payments		7.875%
Reduction in bi-monthly payments resulting from conversion					$ 2,218,500
Conversion price		$ 1.60
Change in fair value - Senior Secured Convertible Note			$ 379,229		340,830
Repayments of debt			1,850,000		3,381,000
Non installment payments settles by shares			$ 89,332		$ 112,293
Non installment payments settles - common shares			2,334,186		3,850,427
Debt extinguishment loss			$ 406,858		$ 666,670
Covenants and other provisions, description					The Company is subject to certain customary affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends, distributions or redemptions, and the transfer of assets, and to have an unrestricted cash balance of at least $1.75 million at each quarterly balance sheet date, among other provisions and covenants.
Covenants and other provisions unrestricted cash balance			$ 1,750,000		$ 1,750,000
Common stock, shares authorized		75,000,000	100,000,000		100,000,000
Securities Purchase Agreement [Member] \| Senior Secured Convertible Note [Member] \| Subsequent Event [Member]
Repayments of debt	$ 150,000
Non installment payments settles by shares	$ 1,641
Non installment payments settles - common shares	202,950
Fair value of adjustment of convertible debt	$ 184,864
Securities Purchase Agreement [Member] \| Senior Convertible Note [Member] \| June 28, 2019 Through November 30, 2020 [Member]
Bi-monthly installment payments					$ 193,750
Securities Purchase Agreement [Member] \| Senior Convertible Note [Member] \| December 15, 2020 [Member]
Bi-monthly installment payments					484,375
Securities Purchase Agreement [Member] \| Senior Convertible Note [Member] \| December 31, 2020 [Member]
Bi-monthly installment payments					$ 484,375